Brimonidine Tartrate Ophthalmic Solution, 0.15% Solution/ Drops
Product Images NDC 62332-661

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate Ophthalmic Solution, 0.15% (NDC 62332-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-bottle-10ml (Brimonidine Bottle 10ml)

This is a description of a prescription eye drop medication called Brimonidine Tartrate Ophthalmic Solution. It contains brimonidine tartrate as the active ingredient and a stabilized oxychloro complex as a preservative. The recommended dosage is one drop in the affected eye(s) three times a day. The solution should be stored between 15°C to 25°C (59°F to 77°F). The medication is manufactured by Alembic Pharmaceuticals and is made in India. The product is sterile and has an expiration date of March 2023.*

FDA Label Image

Brimonidine-bottle-15ml (Brimonidine Bottle 15ml)

Brimonidine Tartrate is an active ingredient present in the Ophthalmic Solution produced by Alembic Pharmaceuticals, Inc. NDC 62382-661-15 Rxonly. It is used for treating affected eyes, and usual dosage is one drop three times a day. The solution is stabilized with oxychloro complex (0.005%) and contains a preservative. The shelf life of the product is till March 2023, and it should be stored in an unvarnished area at a temperature between 15° to 25°C (59°to 77°F).*

FDA Label Image

Brimonidine-bottle-5ml (Brimonidine Bottle 5ml)

This is a description of an ophthalmic solution containing Brimonidine Tartrate, which is used to treat elevated intraocular pressure caused by glaucoma or ocular hypertension. The solution is available with an NDC number of 62332-661-05 and contains Bimoridie tatrte 0.15% S as an active ingredient and stabilized oxychloro Brimonidine Tartrate complex (0.005%) as a preservative. The usual dosage is one drop three times daily to affected eye(s). The solution should be stored at a temperature of 15° to 25°C (59° to 77°F). The product is manufactured by Alembic Pharmaceuticals, Inc. and was made in India. The lot number is 20038314, and the expiration date is not mentioned.*

FDA Label Image

Brimonidine-carton-10ml (Brimonidine Carton 10ml)

This is a label for Brimonidine Tartrate Ophthalmic Solution manufactured by Alembic Pharmaceuticals in India. The label includes batch coding and barcode information, manufacturing and distribution details, a list of ingredients, and dosage instructions for the medication. The solution is sterile and intended for use in the treatment of eye conditions. It should be stored at 15° 0 25°C.*

FDA Label Image

Brimonidine-carton-15ml (Brimonidine Carton 15ml)

This is a description for a Brimonidine Tartrate Ophthalmic Solution medication manufactured by Alembic Pharmaceuticals. It contains 0.15% Brimonidine tartrate as the active ingredient and is used to treat eye conditions. The solution comes in a dropper bottle and should be applied three times per day, eight hours apart. The pH is adjusted using hydrochloric acid and/or sodium hydroxide. It should be stored at a temperature between 15°C and 25°C. The medication is sterile and available only with a prescription.*

FDA Label Image

Brimonidine-carton-5ml (Brimonidine Carton 5ml)

This is a label containing details of a pharmaceutical product. It includes information on the batch coding, barcode, manufacturer, active and inactive ingredients, dosage instructions, and storage information.*

FDA Label Image

Brimonidine-structure (Brimonidine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.